When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. Keeping that in mind, here is one stock where you should be greedy instead of fearful and two facing legitimate challenges.

Consensus Price Target: $55.25 (-4.1% implied return)

Founded in 1895, Albany (NYSE:AIN) is a global textiles and materials processing company, specializing in machine clothing for paper mills and engineered composite structures for aerospace and other industries.

Why Do We Steer Clear of AIN?

Annual revenue growth of 2.5% over the last two years was below our standards for the industrials sector

Free cash flow margin shrank by 9.9 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive

Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned

At $57.60 per share, Albany trades at 20.3x forward P/E. If you’re considering AIN for your portfolio, see our FREE research report to learn more.

Consensus Price Target: $281.63 (7.8% implied return)

With a mission critical role in preventing healthcare-associated infections, STERIS (NYSE:STE) provides infection prevention products, sterilization services, and medical equipment that help healthcare facilities and life science companies maintain sterile environments.

Why Does STE Fall Short?

Low returns on capital reflect management’s struggle to allocate funds effectively

STERIS is trading at $261.18 per share, or 24.3x forward P/E. To fully understand why you should be careful with STE, check out our full research report (it’s free).

Consensus Price Target: $178.41 (14% implied return)

With over $1 trillion in assets under management and investments spanning real estate, private equity, credit, and hedge funds, Blackstone (NYSE:BX) is a global alternative asset manager that invests capital on behalf of pension funds, sovereign wealth funds, and other institutional investors.

Why Is BX a Top Pick?

Market share has increased this cycle as its 19.2% annual revenue growth over the last five years was exceptional

Fee-related earnings increased by 22.7% annually over the last five years as it refined its cost structure

Earnings growth has easily exceeded the peer group average over the last five years as its EPS has compounded at 19.7% annually

Blackstone’s stock price of $156.50 implies a valuation ratio of 25.1x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.

Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.